1. Prognostic factors associated with resectable carcinoma of the esophagus.
食管癌和贲门癌的外科治疗。
来自互联网
2. Purpose: To test the safety of neoadjuvant chemotherapy for resectable pancreatic cancer.
目的：验证可手术胰腺癌新辅助化疗的安全性。
来自互联网
3. Pancreaticobiliary malignancies are difficult to diagnose in the early stage and only a few of them are resectable.
胰胆系恶性肿瘤早期诊断困难，手术切除率低。
来自互联网
4. The microsphere for hepatic arterial embolization is a newdosage form for treatment of non-resectable liver cancer.
肝动脉栓塞微球是用于治疗中晚期肝癌的新剂型。
来自互联网
5. Objective To improve the technique of bloodless hepatectomy to elevate the resectable rate of massive hepatic tumors.
目的改进无血切肝技术，提高肝脏巨大肿瘤的切除率。
来自互联网
6. The microsphere for hepatic arterial embolization is a new dosage form in the treatment of non-resectable liver cancer.
肝动脉栓塞微球是用于治疗中晚期肝癌的新剂型。
来自互联网
7. Objective: To explore emergency operation for resectable colon carcinoma with acute ileus so as to promote operative effect.
目的：探讨可切除结肠癌急性肠梗阻的急诊手术治疗，促进手术疗效的提高。
来自互联网
8. Objective: to explore the related factors that can influence the prognosis of patients with resectable hilar cholangiocarcinoma.
目的：探讨影响可手术切除的肝门部胆管癌患者预后的相关因素。
来自互联网
9. Objective To explore the effect of pre-operative adjuvant chemo-radiotherapy and surgical treatment on resectable esophageal cancer.
目的探讨术前新辅助放化疗在可切除食管癌治疗中的作用。
来自互联网
10. Objective:To explore the relationship between the puncture point, angle, quantities of resectable nucleus pulposus and clinical curative effect.
目的：探讨经皮穿刺切吸腰椎间盘术中，穿刺点、角度、髓核组织取出量与临床疗效的关系。
来自互联网
11. Conclusion Preoperative TACE for resectable large HCC damages liver function, increases surgical difficulty and risk, maybe delay operation chance.
结论大肝癌术前TACE使肝功能受损，增加手术难度及手术风险，并有可能耽误手术时机。
来自互联网
12. ObjectiveTo examine the effect of preoperative arterial chemotherapy on resectable rate and radical rate of the patients with advanced gastric cancer.
目的探讨术前动脉化疗对进展期胃癌手术切除率和根治率的影响。
来自互联网
13. Conclusion Preoperative arterial chemotherapy can elevate the resectable rate and radical rate of the patients with advenced gastric cancer underwent surgery.
结论术前动脉化疗能提高进展期胃癌患者的手术切除率和根治率。
来自互联网
14. To determine the benefits and harms of liver resection versus other treatments in patients with resectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours.
判定肝脏切除对照其他疗法治疗起源于胃肠胰神经内分泌肿瘤的可切除肝转移病人的利弊。
来自互联网
15. Objective: to study the influence of preoperative transcatheter arterial chemoembolization (TACE) by selection on survival rate of resectable hepatocellular carcinoma (HCC) patients.
目的：探讨术前选择性经肝动脉化疗栓塞对肝癌患者手术治疗效果的影响。
来自互联网
16. Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
来自互联网
17. Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
来自互联网
18. Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
